Oxidative stress-elicited myocardial apoptosis during reperfusion

Zhi-Qing Zhao1

  • 1Cardiothoracic Research Laboratory, The Carlyle Fraser Heart Center/Crawford Long Hospital, Emory University School of Medicine, 550 Peachtree St NE, Atlanta, GA 30308-2225, USA. zzhao@emory.edu

Insights

Reactive oxygen species (ROS) drive myocardial apoptosis during reperfusion, leading to cardiac dysfunction. Antioxidant therapies targeting ROS show promise for treating ischemia/reperfusion injury.

Area of Science:

  • Cardiovascular Research
  • Cellular Biology
  • Biochemistry

Background:

  • Myocardial apoptosis during reperfusion contributes to cardiac dysfunction and infarct expansion.
  • Signaling pathways triggering apoptosis are not fully understood, but reactive oxygen species (ROS) are implicated.
  • Elevated ROS levels promote inflammation, endothelial cell interactions, and calcium overload, releasing mitochondrial pro-apoptotic factors.

Purpose of the Study:

  • To elucidate the role of reactive oxygen species (ROS) in myocardial apoptosis during ischemia/reperfusion (I/R) injury.
  • To explore the molecular mechanisms by which ROS induce apoptosis.
  • To assess the therapeutic potential of antioxidants in mitigating I/R-induced cardiac damage.

Main Methods:

  • Review of experimental evidence implicating ROS in apoptosis.
  • Analysis of ROS-mediated signaling cascades including mitogen-activated protein kinases and nuclear factor-kappaB.
  • Evaluation of studies demonstrating antioxidant effects on apoptosis and I/R injury.

Main Results:

  • ROS generation is a key trigger for myocardial apoptosis post-reperfusion.
  • ROS activate pro-apoptotic pathways, including mitochondrial gene release, MAPK activation, NF-kappaB stimulation, and TNF-alpha synthesis.
  • Antioxidant interventions have shown efficacy in reducing apoptosis and limiting I/R injury.

Conclusions:

  • Reactive oxygen species (ROS) play a critical role in mediating myocardial apoptosis following ischemia/reperfusion.
  • Targeting ROS with antioxidants represents a viable therapeutic strategy for managing cardiac dysfunction and infarct size in I/R injury.
  • Further research into ROS-scavenging mechanisms could lead to novel treatments for cardiovascular diseases.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Cellular Injury I: Introduction01:00

Cellular Injury I: Introduction

Cellular injury occurs when a cell cannot maintain homeostasis or adapt to stressors such as hypoxia, toxins, or trauma. Depending on severity and duration, injury may be reversible, allowing recovery, or irreversible, leading to cell death.General Mechanisms of Cell InjuryAlthough causes vary, most cellular injuries arise from a few key mechanisms that disrupt essential functions and often amplify one another. Cell survival depends on the extent and balance of these disturbances.ATP depletion...
Cellular Injury IV: Necrosis01:16

Cellular Injury IV: Necrosis

Necrosis is a form of irreversible cell death caused by severe injury such as ischemia, toxins, or trauma. Unlike programmed cell death, it is an uncontrolled, pathological process that typically provokes inflammation in surrounding tissues.Pathophysiologic ChangesNecrosis begins when cells sustain critical damage, leading to swelling of organelles, particularly mitochondria, and rapid ATP depletion. As energy levels decline, membrane ion pumps fail, leading to calcium influx and eventually,...